ALIDHE phase 3b study design: ivosidenib + azacitidine in adults with newly diagnosed IDH1 mutant acute myeloid leukemia
Christian Récher, Samantha Nier, Robert K. Hills, Anne-Marie De La Bigne et al.
Citations
1 citations
Journal
Future Oncology
Topics
Acute Myeloid Leukemia Research
Field-Weighted Citation Impact (FWCI)
1.77
article
ALIDHE phase 3b study design: ivosidenib + azacitidine in adults with newly diagnosed IDH1 mutant acute myeloid leukemia
Christian Récher, Samantha Nier, Robert K. Hills, Anne-Marie De La Bigne, Sam Salek, Jana Pelouchová, Paresh Vyas, Hartmut Döhner, Susana Vives, Hélène Derrien, Adriano Venditti, Stéphanie Chatin
article en
1 citations
Abstract
No abstract available for this paper.
Publication Tag
Future OncologyVol. 21(29)
Institutions
University of Rome Tor Vergata (IT), Universitat Autònoma de Barcelona (ES), Advocates for Youth (US), Université Toulouse III - Paul Sabatier (FR), University of Hertfordshire (GB), Centre Hospitalier Universitaire de Toulouse (FR), University of Oxford (GB), Centre de Recherches en Cancérologie de Toulouse (FR), Institut universitaire du cancer de Toulouse Oncopole (FR), MRC Weatherall Institute of Molecular Medicine (GB), The Alan Turing Institute (GB), Servier (France) (FR), Hospital Universitari Germans Trias i Pujol (ES), University Hospital Ulm (DE)